Al Jazeera· World
GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
Published Saturday, 25 July 2026 at 00:40
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
This is a syndicated summary. Read the full story at the original publisher:
Read on Al Jazeera →